Can you get Wegovy without being overweight? Here's the honest answer

Your consultation with nume is completely free — no payment until a prescriber decides treatment is clinically appropriate for you.
A real, named GPhC-registered Independent Prescriber reads your answers the same day; no automated decisions, no black-box algorithms.
Once approved, orders placed before midday Monday to Friday are dispatched that afternoon and delivered free the next working day by DPD, in plain unbranded packaging.
One transparent price covers the prescription, the medicine, delivery, and 7-day-a-week priority aftercare, no subscription, no surprise add-ons, and no automatic renewals.

Wegovy is licensed in the UK for adults with a BMI of 30 or above, or 27 or above when at least one weight-related health condition is present — so 'without being overweight' in the clinical sense is not the typical route, and no regulated prescriber can legally approve it outside those thresholds. That said, many people asking this question are closer to eligibility than they realise. If you carry extra weight alongside a health condition such as high blood pressure, high cholesterol, prediabetes or obstructive sleep apnoea, you may well qualify at a free consultation even if you don't think of yourself as obese. These are prescription-only medicines requiring individual clinical assessment; a prescriber looks at your full picture, not just a number on a scale. It's worth getting that picture properly before ruling yourself out.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding what actually determines eligibility, and the decision you're really facing

The licence criteria: where the BMI thresholds sit and why they exist

Wegovy (semaglutide) holds a UK marketing authorisation for weight management in adults with a BMI of 30 or above, or from 27 upwards if at least one weight-related condition is part of the picture. NHS guidance on semaglutide is clear that the medicine is not licensed for use below those thresholds in the general adult population, and a legitimate prescriber will not approve it outside them, regardless of how the request is framed. Those thresholds exist because the clinical trials that generated the safety and efficacy data enrolled participants within them; prescribing outside that boundary means prescribing without the evidence base that supports the benefit-risk calculation. For South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, UK guidance applies thresholds 2.5 kg/m² lower throughout, so some people who think they fall short may not. If you are unsure whether your BMI meets the threshold, the NHS BMI calculator is a useful starting point before a consultation. The point is not to present a barrier but to set an accurate baseline for the decision you're about to make.

The condition that might tip the balance: weight-related comorbidities explained

The part of the eligibility criteria that surprises most people is the lower BMI band paired with a qualifying health condition. If your BMI sits at 27 or above and you live with high blood pressure, dyslipidaemia, type 2 diabetes or prediabetes, obstructive sleep apnoea, or certain cardiovascular conditions, you may meet the licensed criteria for Wegovy even though you don't consider yourself significantly overweight. A lot of people coming to us have been carrying a diagnosis like that quietly for years without connecting it to a weight-management conversation. The prescriber's job during the consultation is to take all of that into account together: your BMI, your health history, any medicines you're already taking, and whether the benefit of treatment outweighs any risks for you specifically. How Wegovy is prescribed for weight loss goes into more detail on what that assessment covers. The key thing to know here is that BMI alone is never the whole story, and if your situation feels borderline, our page on how to get Wegovy if you're not overweight walks through the specific circumstances where treatment may still be possible.

The legal route to Wegovy in the UK, and how to verify any pharmacy you consider

Wegovy is a Prescription-Only Medicine. The only legal path to it in the UK is a prescription issued by a qualified prescriber following a genuine clinical assessment of your individual circumstances. That assessment can happen through the NHS (though NHS access follows strict phased criteria and waiting lists can be substantial) or through a regulated private pharmacy such as ours. Before using any online pharmacy, you can and should check it holds a GPhC premises registration. Our pharmacy registration number is 9012878, verifiable directly at the GPhC pharmacy register. The MHRA has warned repeatedly about fake weight-loss pens sold online without any clinical process, in some cases, counterfeit pens have contained entirely different substances. Any seller offering semaglutide without a prescription, via social media, or at prices far below the recognised market range should be treated as a serious red flag. You can report suspect sellers through the MHRA's Yellow Card scheme. If you're wondering what a legitimate process actually looks like, our page on getting Wegovy without a prescription explains exactly why that route doesn't legally exist, and our page covering Wegovy without a prescription being issued sets out what to watch for when you encounter offers that skip that step entirely.

What the decision really comes down to

If you're reading this, there's a reasonable chance you're not sure whether you qualify, and that uncertainty is worth resolving properly rather than guessing. Many people talk themselves out of a consultation because they don't identify with clinical language around obesity, yet they meet the criteria on paper. Others come in hopeful and find the thresholds genuinely aren't met, which is also important to know before spending money or time. Our prescribers review every consultation individually, ask the right questions, and give a straightforward answer. If Wegovy isn't the right fit, they'll say so. You can read more about our clinical approach or look at the range of weight-loss treatments we assess people for. If you have a specific question before starting, our FAQs cover the ones we hear most often. The consultation itself costs nothing. Speak to our prescribers and find out where you actually stand.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions